169 related articles for article (PubMed ID: 18691650)
1. Dissolution enhancement of the anti-HIV drug UC 781 by formulation in a ternary solid dispersion with TPGS 1000 and Eudragit E100.
Goddeeris C; Willems T; Houthoofd K; Martens JA; Van den Mooter G
Eur J Pharm Biopharm; 2008 Nov; 70(3):861-8. PubMed ID: 18691650
[TBL] [Abstract][Full Text] [Related]
2. Formulation of fast disintegrating tablets of ternary solid dispersions consisting of TPGS 1000 and HPMC 2910 or PVPVA 64 to improve the dissolution of the anti-HIV drug UC 781.
Goddeeris C; Willems T; Van den Mooter G
Eur J Pharm Sci; 2008 Aug; 34(4-5):293-302. PubMed ID: 18602800
[TBL] [Abstract][Full Text] [Related]
3. Free flowing solid dispersions of the anti-HIV drug UC 781 with Poloxamer 407 and a maximum amount of TPGS 1000: investigating the relationship between physicochemical characteristics and dissolution behaviour.
Goddeeris C; Van den Mooter G
Eur J Pharm Sci; 2008 Sep; 35(1-2):104-13. PubMed ID: 18644442
[TBL] [Abstract][Full Text] [Related]
4. Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects.
Prasad D; Chauhan H; Atef E
J Pharm Sci; 2014 Nov; 103(11):3511-3523. PubMed ID: 25196860
[TBL] [Abstract][Full Text] [Related]
5. Lecithin/TPGS-based spray-dried self-microemulsifying drug delivery systems: In vitro pulmonary deposition and cytotoxicity.
Ishak RA; Osman R
Int J Pharm; 2015 May; 485(1-2):249-60. PubMed ID: 25772421
[TBL] [Abstract][Full Text] [Related]
6. Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties.
Duret C; Wauthoz N; Sebti T; Vanderbist F; Amighi K
Int J Pharm; 2012 May; 428(1-2):103-13. PubMed ID: 22414388
[TBL] [Abstract][Full Text] [Related]
7. Role of Molecular Interactions for Synergistic Precipitation Inhibition of Poorly Soluble Drug in Supersaturated Drug-Polymer-Polymer Ternary Solution.
Prasad D; Chauhan H; Atef E
Mol Pharm; 2016 Mar; 13(3):756-65. PubMed ID: 26866895
[TBL] [Abstract][Full Text] [Related]
8. Characterization and stability of solid dispersions based on PEG/polymer blends.
Bley H; Fussnegger B; Bodmeier R
Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875
[TBL] [Abstract][Full Text] [Related]
9. Characterization of solid dispersions of itraconazole and vitamin E TPGS prepared by microwave technology.
Moneghini M; De Zordi N; Solinas D; Macchiavelli S; Princivalle F
Future Med Chem; 2010 Feb; 2(2):237-46. PubMed ID: 21426191
[TBL] [Abstract][Full Text] [Related]
10. Solid dispersion of berberine-phospholipid complex/TPGS 1000/SiO₂: preparation, characterization and in vivo studies.
Zhang Z; Chen Y; Deng J; Jia X; Zhou J; Lv H
Int J Pharm; 2014 Apr; 465(1-2):306-16. PubMed ID: 24456672
[TBL] [Abstract][Full Text] [Related]
11. Formulation and characterization of ternary solid dispersions made up of Itraconazole and two excipients, TPGS 1000 and PVPVA 64, that were selected based on a supersaturation screening study.
Janssens S; Nagels S; Armas HN; D'Autry W; Van Schepdael A; Van den Mooter G
Eur J Pharm Biopharm; 2008 May; 69(1):158-66. PubMed ID: 18164929
[TBL] [Abstract][Full Text] [Related]
12. Enhanced supersaturation and oral absorption of sirolimus using an amorphous solid dispersion based on Eudragit® e.
Cho Y; Ha ES; Baek IH; Kim MS; Cho CW; Hwang SJ
Molecules; 2015 May; 20(6):9496-509. PubMed ID: 26020699
[TBL] [Abstract][Full Text] [Related]
13. An Extrusion Spheronization Approach to Enable a High Drug Load Formulation of a Poorly Soluble Drug with a Low Melting Surfactant.
Tatavarti A; Kesisoglou F
J Pharm Sci; 2015 Nov; 104(11):3752-3759. PubMed ID: 26205160
[TBL] [Abstract][Full Text] [Related]
14. Itraconazole/TPGS/Aerosil200 solid dispersions: characterization, physical stability and in vivo performance.
Van Eerdenbrugh B; Van Speybroeck M; Mols R; Houthoofd K; Martens JA; Froyen L; Van Humbeeck J; Augustijns P; Van den Mooter G
Eur J Pharm Sci; 2009 Oct; 38(3):270-8. PubMed ID: 19686846
[TBL] [Abstract][Full Text] [Related]
15. Increased physical stability and improved dissolution properties of itraconazole, a class II drug, by solid dispersions that combine fast- and slow-dissolving polymers.
Six K; Verreck G; Peeters J; Brewster M; Van Den Mooter G
J Pharm Sci; 2004 Jan; 93(1):124-31. PubMed ID: 14648642
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of solubility and dissolution of cilostazol by solid dispersion technique.
Park JH; Choi HK
Arch Pharm Res; 2015 Jul; 38(7):1336-44. PubMed ID: 25567762
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic study of solubility enhancement of nifedipine using vitamin E TPGS or solutol HS-15.
Rajebahadur M; Zia H; Nues A; Lee C
Drug Deliv; 2006; 13(3):201-6. PubMed ID: 16556572
[TBL] [Abstract][Full Text] [Related]
18. Impact of surfactants on the crystal growth of amorphous celecoxib.
Mosquera-Giraldo LI; Trasi NS; Taylor LS
Int J Pharm; 2014 Jan; 461(1-2):251-7. PubMed ID: 24333451
[TBL] [Abstract][Full Text] [Related]
19. Dissolution improvement of high drug-loaded solid dispersion.
Okonogi S; Puttipipatkhachorn S
AAPS PharmSciTech; 2006 Jun; 7(2):E52. PubMed ID: 16796369
[TBL] [Abstract][Full Text] [Related]
20. Effect of hydrophilic additives on the dissolution and pharmacokinetic properties of itraconazole-enteric polymer hot-melt extruded amorphous solid dispersions.
Lang B; Liu S; McGinity JW; Williams RO
Drug Dev Ind Pharm; 2016; 42(3):429-45. PubMed ID: 26355819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
